KP
BIIB icon

Kiltearn Partners’s Biogen BIIB Stock Holding History

Kiltearn Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-190,200
Closed -$56.4M – 25
2019
Q4 		$56.4M Sell
190,200
-21,000
-10% -$5.83M 2.13% 23
2019
Q3 		$48.6M Sell
211,200
-17,300
-8% -$4.03M 1.77% 25
2019
Q2 		$53.4M Sell
228,500
-21,900
-9% -$5.06M 1.69% 25
2019
Q1 		$59.2M Buy
250,400
+75,500
+43% +$23.8M 1.68% 26
2018
Q4 		$52.6M Buy
+174,900
New +$55.8M 1.48% 26

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Kiltearn Partners's BIIB Position: Q1 2020 in Review

Kiltearn Partners sold out of Biogen (BIIB) in Q1 2020, closing a stake of 190,200 shares — an estimated $56.4M sold.

Kiltearn Partners first reported a position in BIIB in Q4 2018 and held it in 5 quarters. The position peaked at $59.2M in Q1 2019. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q1 2020.

  • Kiltearn Partners reported no remaining Biogen position as of Q1 2020 after selling out during the quarter.
  • Kiltearn Partners sold 190,200 Biogen shares in Q1 2020, an estimated $56.4M.
  • Kiltearn Partners first reported a position in Biogen in Q4 2018 and held it in 5 quarters.
  • Kiltearn Partners's Biogen position peaked at $59.2M in Q1 2019.
  • 1,098 funds tracked by Wall St. Rank held Biogen as of Q1 2020.

Based on Kiltearn Partners's 13F filing for Q1 2020, filed 14 May 2020.